Company Profile
Astonea Labs Ltd is an Indian pharmaceutical and cosmeceutical company based in Panchkula, Haryana. With over three decades of experience, the company operates primarily as a third-party manufacturer for a wide range of medical and wellness products. These include tablets, capsules, powders, creams, lotions, and softgel formulations.
Astonea’s manufacturing facilities meet international quality and regulatory standards, holding certifications such as WHO-GMP, ISO, HALAL, and ECO CERT. These facilities are designed to meet the requirements of both domestic and export markets, ensuring consistent quality and safety.
The company produces and supplies products across multiple therapeutic areas including dermatology, gynecology, oncology, urology, cardiology, and diabetes care. Its growing product portfolio spans approximately 1,700 distinct items, allowing it to serve a diverse client base.
Business Model
Astonea Labs Ltd operates a contract manufacturing and private labeling business model within the pharmaceutical and cosmeceutical sectors. The company produces a wide range of healthcare and wellness products for other companies, rather than selling under its own consumer-facing brand.
🔧 Core Components of the Business Model:
- Third-Party Manufacturing
- Astonea produces medicines, skincare products, and nutritional supplements on behalf of other pharmaceutical companies.
- Clients provide product specifications, and Astonea handles the manufacturing using its certified facilities.
- Private Label Services
- The company offers end-to-end services from product development to packaging, allowing clients to market the products under their own brand names.
- Diverse Product Portfolio
- It manufactures a broad range of dosage forms: tablets, capsules, softgels, creams, ointments, gels, lotions, and powders across several therapeutic segments.
- Export-Oriented Production
- Astonea aims to expand its presence in international markets, with products and processes designed to meet global standards.
- Custom Formulation & R&D
- The company supports custom formulation development for clients and provides R&D services to help them launch new and innovative products.
- Regulatory and Certification Support
- Astonea helps clients with regulatory documentation and ensures compliance with WHO-GMP, ISO, HALAL, ECO CERT, and other international quality standards.
Product Portfolio
Astonea Labs Ltd offers a diverse and comprehensive range of pharmaceutical and cosmeceutical products. The company manufactures over 1,700 stock keeping units (SKUs) across multiple dosage forms and therapeutic areas, catering to clients in both domestic and international markets.
🔹 Dosage Forms
- Tablets
- Capsules (Hard Gelatin and Softgel)
- Powders (Sachets, Oral Rehydration, Nutritional Supplements)
- Creams and Ointments
- Lotions and Gels
- Liquid Formulations (Syrups, Suspensions)
🔹 Therapeutic Segments
- Dermatology
- Skin creams, antifungal ointments, acne treatments, moisturizers, etc.
- Gynecology
- Supplements for women’s health, hormonal support, intimate care products.
- Urology
- Products targeting kidney, bladder, and urinary health.
- Oncology Support
- Nutritional supplements and topical formulations for cancer care support.
- Cardiology
- Heart health supplements and related medications.
- Diabetology
- Sugar-control tablets, insulin-support supplements, and diabetic foot care.
- Gastroenterology
- Antacids, probiotics, digestive enzyme powders, and more.
- Renal Health
- Specialized nutrition and support products for kidney function.
🧪 Additional Categories
- Nutraceuticals
- Protein powders, herbal supplements, and vitamin blends.
- Cosmeceuticals
- Medicated and herbal skincare products including anti-aging creams, sunscreens, and fairness lotions.
- Pediatric Care
- Mild, child-friendly formulations for common ailments and nutritional needs.
🌍 Export-Ready Formulations
Many products are designed and manufactured to comply with international standards, making them suitable for regulated and emerging global markets.
Financial Snapshot (as of March 31, 2024)
📊 Financial Highlights (₹ in Crores)
| Metric | Amount (₹ Crore) | Year-over-Year Growth |
|---|---|---|
| Revenue from Operations | 80.19 | +19.5% |
| Profit After Tax (PAT) | 3.80 | +467% |
| Total Assets | 80.89 | +25.8% |
| Net Worth | 11.97 | +46.7% |
| Reserves & Surplus | 4.37 | +5.0% |
| Total Borrowings | 42.40 | +17.8% |
📈 Key Financial Ratios
| Ratio | Value | Interpretation |
|---|---|---|
| Net Profit Margin | 4.74% | Indicates that the company retains ₹4.74 as profit for every ₹100 of revenue. |
| Return on Equity (ROE) | 31.74% | Reflects strong profitability, generating ₹31.74 profit for every ₹100 of equity. |
| Return on Capital Employed | 9.86% | Shows efficient use of capital, yielding ₹9.86 for every ₹100 invested. |
| Debt-to-Equity Ratio | 3.54 | Suggests a high reliance on debt financing, with ₹3.54 of debt for every ₹1 of equity. |
| Current Ratio | 1.20 | Indicates adequate short-term liquidity, with ₹1.20 in assets for every ₹1 of liabilities. |
Initial Public Offering (IPO) Plans
| Component | Details |
|---|---|
| Issue Size | ₹3,500 crore |
| Fresh Issue | ₹2,500 crore |
| Offer for Sale (OFS) | ₹1,000 crore (by Brookfield) |
| Price Band | ₹413 – ₹435 per share |
| IPO Open Dates | May 26 – May 28, 2025 |
| Anchor Investor Date | May 23, 2025 |
| Expected Listing Date | June 2, 2025 (BSE and NSE) |
| Valuation | Approx. ₹14,500 crore at upper price band |
💼 Use of IPO Proceeds
- Repayment of Debt: A major portion will go toward reducing existing borrowings.
- General Corporate Purposes: To support operations and future expansion.
- Strengthen Balance Sheet: Improve leverage and credit profile.
Objectives of the Issue
Astonea Labs Ltd, a pharmaceutical and cosmeceutical manufacturer based in Panchkula, India, is set to launch its Initial Public Offering (IPO) on the BSE SME platform. The IPO is designed to raise funds to support the company’s growth and expansion initiatives.
🧾 IPO Highlights (as per latest available info)
- IPO Type: SME IPO (Book-built issue)
- Exchange: BSE SME
- Total Issue Size: To be announced (TBA)
- Price Band: TBA
- Lot Size: TBA
- Minimum Investment: TBA
- Tentative Dates: Expected around May–June 2024
🎯 Objectives of the IPO
Astonea Labs plans to use the IPO proceeds for:
- Upgrading Manufacturing Capabilities
Installation of new machinery for ointment and cream production targeting export markets. - Product Registration and Compliance
Investment in certifications and approvals needed to enter new international markets. - Brand Development
Advertising and marketing to strengthen its presence in India and abroad. - Technology Enhancement
Upgrades to IT infrastructure, including hardware and software. - Working Capital Needs
Funding day-to-day operations and inventory management. - General Corporate Purposes
Supporting the company’s overall strategic goals and stability.
Future Outlook
Astonea Labs Ltd is well-positioned for growth, building on its established expertise in pharmaceutical and cosmeceutical manufacturing. The company is focused on expanding its presence in international markets and enhancing its range of products.
Key Growth Areas:
- International Expansion
The company aims to increase its footprint in existing markets like the USA, Europe, and Africa, while entering new regions to diversify its global reach. - Product Innovation
Investment in research and development is a priority to create new formulations and adapt to evolving market demands. - Sustainability
Astonea Labs is committed to eco-friendly manufacturing processes, including waste reduction and resource efficiency. - Financial Growth
The company anticipates steady revenue growth supported by expansion and modernization initiatives.
🧭 Vision and Leadership
Vision
Astonea Labs Ltd aims to be a global leader in pharmaceuticals and cosmeceuticals by:
- Creating sustainable, impactful brands recognized worldwide
- Expanding its presence in international markets through trusted products
- Innovating and offering a diverse portfolio of well-researched products
Leadership Team
The company is guided by a skilled leadership team with expertise across engineering, pharmacy, finance, manufacturing, marketing, and corporate governance. Key leaders include:
- Founder & Managing Director with a technical and visionary background
- Directors with deep experience in pharmacy, quality assurance, and regulatory affairs
- Financial and operational heads ensuring sound management and growth
- Marketing and company secretary professionals supporting strategic initiatives
Market Positioning and Growth Prospects
📍 Market Positioning
Astonea Labs Ltd is a well-established company in the pharmaceutical and cosmeceutical sectors, known for its high-quality manufacturing and innovative products. The company operates advanced facilities that meet global quality certifications, serving both domestic and international clients.
Key Focus Areas:
- Providing contract manufacturing services for pharmaceuticals, cosmetics, and nutraceuticals.
- Developing proprietary brands marketed across various regions.
- Exporting products to over 20 countries worldwide.
📈 Growth Prospects
Astonea Labs is expected to grow steadily by:
- Entering new international markets, including parts of Latin America and Africa.
- Expanding and diversifying its product range across several therapeutic areas.
- Committing to sustainable and eco-friendly manufacturing processes.
